Transonic Systems and EMKA Technologies Announce Distribution Expansion
Ithaca, NY (PRWEB) March 24, 2015 -- Transonic is pleased to announce an extended cooperation agreement with Emka Technologies (Paris, France) to distribute Transonic Scisense pressure and pressure volume products. This expands the scope of Emka's current distribution of Transonic's flow measurement products within France to include Transonic Scisense products in the rest of the world outside of the USA. Transonic Scisense’s unique Admittance Pressure-Volume measurements provide the most comprehensive hemodynamic data for the study of Cardiac Function and contractility in heart failure studies.
The Transonic family of companies is excited about its expanded partnership with Emka Technologies. Andrew Bloom, Transonic Vice-President for worldwide sales notes, The distribution of the Transonic Scisense product line by Emka Technologies increases its offering throughout the world and advances the growth strategy for this product line.” He continues, “Transonic and Emka’s combined focus on the Scisense pressure and pressure-volume catheters and systems allows for a worldwide ramp up in product distribution and support”.
Jean-Gérard Napoléoni, CEO of Emka Scireq group confirms that “Transonic and Emka have worked together for to 20 years and this expanded scope of cooperation is very promising and will significantly strengthen our joint footprint on the cardio-vascular research market worldwide.”
For over three decades, Transonic has been offering quantitative data solutions to clinicians, researchers and specialty device manufacturers. The unprecedented resolution of Transonic products has made the Transonic name synonymous with gold standard diagnostic and research measurements.
Emka Technologies offers integrated hardware and software solutions for pharmacology, safety pharmacology and toxicology in the fields of cardio-vascular, respiratory and CNS research.
Miriam Tenorio, Transonic Systems Inc., http://www.transonic.com, +1 (607) 257-5300, [email protected]
Share this article